Genzyme Fights To Keep Anika's Monovisc Out Of US
Genzyme Corp. has launched an infringement suit against Anika Therapeutics Inc. in an effort to block a drug that allegedly infringes two patents covering osteoarthritis treatment technology....To view the full article, register now.
Already a subscriber? Click here to view full article